Ezedoc
✅ Lowers Cholesterol Levels
✅ Reduces Heart Disease Risk
✅ Prevents Atherosclerosis
✅ Prescribed by Doctors
✅ Oral Medication Option
Ezedoc contains Ezetimibe.
✓ Lääketieteellinen tarkistus Morgan Ellis — Farmasian tutkija · 8 vuoden kokemus · Viimeisin arvio: toukokuu 2026
⚡ Quick Answer — What is Ezedoc?
Ezedoc sisältää ezetimibe (10 mg), a cholesterol-absorption inhibitor that blocks the NPC1L1 transporter in the small intestine. It is the go-to add-on therapy when a statin alone doesn’t get LDL to target. On its own, ezetimibe lowers LDL-C by about 17–22%. Added to a statin, it produces an additional ~20–25% LDL reduction, totaling a 55–60% fall — equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The IMPROVE-IT trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10 mg once daily, any time, with or without food. Generally very well-tolerated — mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.
📦 Jokainen tilaus on katettuna meidän Reshipment Assurance Policy -politiikkamme piiriin — jos lähetyksesi ei saavu 20 arkipäivässä, lähetämme uuden.
Miksi tilata MedsBasesta
Geneeriset lääkkeemme on hankittu WHO-GMP sertifioiduilta valmistajilta ja toimitettu maailmanlaajuisesti hienotunteisessa, neutraalissa pakkauksessa — lääkkeen nimeä ei ole pakkauksen ulkopuolella. Korttimaksut käsitellään säädeltyjen maksunvälittäjien kautta (tilisiirtojen kuvaukset sisältävät säädellyn korttimaksun käsittelijän — ei koskaan “MedsBase” tai lääkkeen nimeä). Kryptovaluutat ja SEPA-pankkisiirrot hyväksytään myös. Jokainen tilaus on turvattu meidän Reshipment Assurance Policy -takuuohjelmalla.
What Is Ezedoc?
Ezedoc is an oral lipid-lowering medicine containing ezetimibe (10 mg), manufactured by WHO-GMP certified manufacturer. Supplied in packs of 30, 60, 90 or 180 tablets. Ezetimibe is the first and only drug of the cholesterol-absorption inhibitor class. Originator brand: Zetia / Ezetrol (Merck, 2002).
Ezetimibe is a mainstay of second-line lipid management — the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin/ezetimibe = Inegy/Vytorin; rosuvastatin/ezetimibe = various).
What Is Ezedoc Used For?
- Primary hypercholesterolaemia — as add-on to a statin when LDL is not at goal on the maximum tolerated statin dose
- Statin intolerance — as monotherapy or with a very low statin dose when a full statin dose causes muscle or liver problems
- Perinnöllinen hyperkolesterolemia (heterozygous and homozygous) — in combination with statin
- Secondary prevention after acute coronary syndrome — add to statin to further reduce CV events (IMPROVE-IT trial)
- Sitosterolaemia — a rare genetic condition where ezetimibe is disease-modifying
Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30–60%); it is most powerful as an add-on.
How Does Ezedoc Work?
Ezetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) transporter on enterocytes in the proximal small intestine. NPC1L1 is responsible for absorbing dietary and biliary cholesterol from the gut lumen into the enterocyte.
With NPC1L1 blocked:
- Intestinal cholesterol absorption falls by ~54%
- Hepatic cholesterol stores decrease because less cholesterol reaches the liver
- LDL receptors are upregulated on hepatocytes — the liver pulls more LDL out of the blood
- Plasma LDL-C falls by 17–22% as monotherapy; up to 25% additional when combined with a statin
- HMG-CoA reductase activity (the statin target) is unchanged
Because ezetimibe and statins act on complementary pathways (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption/input. Together they drop LDL more than either can alone, without adding to each other’s side-effect profile.
Outcome data: the IMPROVE-IT trial (2015) showed adding ezetimibe to simvastatin in post-ACS patients reduced the composite CV endpoint by 6.4% (NNT 50 over 7 years), confirming that the LDL-lowering translates into real event reduction.
Annostelu ja käyttö
Vakioannos: 10 mg once daily at any time of day, with or without food.
- Take at a consistent time for adherence.
- Can be taken at the same time as a statin or spaced out — no timing interaction.
- Miss a dose — take it as soon as you remember unless close to the next; do not double up.
- No dose adjustment needed for renal impairment or mild-to-moderate hepatic impairment.
- Monitor lipid panel and ALT at baseline and 6–8 weeks after starting. Check CK only if symptoms.
Haittavaikutukset
Ezetimibe is one of the best-tolerated lipid-lowering drugs. Adverse events are close to placebo rates in trials.
Common (< 5%):
- Mild diarrhoea, flatulence
- Upper respiratory tract infection, sinusitis
- Väsymys
- Arthralgia
Epätavalliset:
- Transaminase elevation — usually small; more common when combined with a statin
- Muscle pain, myalgia, myopathy — rare; primarily when combined with statin
- Hypersensitivity, angioedema, rash
- Pancreatitis — very rare
- Cholelithiasis — very rare
- Thrombocytopenia — very rare
- Rhabdomyolysis — exceedingly rare, almost always in combination with a statin
Lääkeaineenvaihdunta
- Siklosporiini — significantly raises ezetimibe levels (and vice versa). Monitor cyclosporine levels; some guidance suggests avoiding.
- Bile acid sequestrants (cholestyramine, colestipol) — reduce ezetimibe absorption; take ezetimibe at least 2 hours before or 4 hours after.
- Varfariini — occasional INR change reported; monitor when starting.
- Statiinit — no adverse PK interaction; this combination is the therapeutic mainstay.
- Fibrates — fenofibrate/ezetimibe combination is safe; gemfibrozil raises ezetimibe levels and is generally avoided.
Who Should Not Take Ezedoc?
- Moderate-to-severe hepatic impairment (when combined with a statin)
- Active liver disease or persistent transaminase elevation > 3× ULN
- Pregnancy (when combined with a statin)
- Rintaruokinta
- Children < 10 years (insufficient data)
- Known hypersensitivity to ezetimibe
Säilytys
Store Ezedoc below 25°C in a dry place, in the original blister. Keep out of reach of children.
Usein Kysytyt Kysymykset
Can I take Ezedoc instead of a statin?
Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% — much less than a statin (30–60%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.
How does Ezedoc compare to doubling my statin dose?
Doubling a statin dose typically adds ~6% LDL reduction (the statin “rule of 6”). Adding ezetimibe adds ~20–25% LDL reduction. Adding ezetimibe is 3–4× more effective than doubling the statin, and without the dose-related rise in muscle symptoms. This is why modern guidelines favour statin + ezetimibe combination over pushing statin to maximum dose.
Does Ezedoc reduce heart attacks and strokes?
Yes — the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.
When should I take Ezedoc?
Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent — pick a time you will remember consistently. Many patients take it at the same time as their statin.
Does Ezedoc cause muscle pain like statins?
Rarely. Ezetimibe monotherapy shows placebo-level muscle side effects. When combined with a statin, it does not meaningfully increase statin-related muscle symptoms compared with the statin alone.
Where can I buy Ezedoc online?
You can order Ezedoc (10 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide with discreet packaging and genuine WHO-GMP certified manufacturer stock.
Aiheeseen liittyvät kolesterolilääkkeet
- Lipvas — Atorvastatin
- Crestor — Rosuvastatin 5/10/20 mg (AstraZeneca)
- Rosuline — Rosuvastatin
- Atorvatin — Atorvastatin
- Pivasta — Pitavastatin (interaction-clean)
- Lipicard — Fenofibrate (for triglycerides)
- Selaa kaikkia korkean kolesterolitason lääkkeitä
Miksi tilata MedsBasesta
Ezedoc is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our Reshipment Assurance Policy -politiikkamme piiriin. Korttimaksun tiliotteesi näyttää säännellyn maksunvälittäjän (säännelty korttimaksujen käsittelijä), ei koskaan “MedsBase” tai minkään lääkkeen nimeä.
Aiheeseen liittyvät vaihtoehdot
Muut tuotteet Krooniset sairaudet joita asiakkaat myös katsovat:
Lisää vaihtoehtoja korkean kolesterolitason hoidoissa
Luokiteltu MedsBase-tilausmäärän mukaan — mitä muut asiakkaat tässä kategoriassa valitsevat.
| Vahvuus | 10 mg |
|---|---|
| Määrä | 30 tablettia, 60 tablettia, 90 tablettia, 180 tablettia |
Ezedoc
Kysymykset ja vastaukset
Ezedoc
Liittyvät tuotteet
Arvostelut
Ei vielä arvosteluja